KNKwon Joong Na

Kwon Joong Na

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kwon Joong Na has a total of 184 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of liberalised preoperative water intake and intravenous-to-oral transition on patient experience and system efficiency in thoracic surgery: a before-and-after study

    by Seon Yong Bae, Ye Ji Kim, Dae Hyeon Kim, Taeyoung Yun, Ji Hyeon Park, Bubse Na, Kwon Joong Na, Samina Park, Hyun Joo Lee, In Kyu Park, et al.

  • Open Access

    Functional, Volumetric, and Growth Outcomes After Pediatric Bilateral Lung Transplantation

    by Seon Yong Bae, Samina Park, Dae Hyeon Kim, Taeyoung Yun, Ji Hyeon Park, Bubse Na, Kwon Joong Na, Hyun Joo Lee, Ji Soo Park, Dong In Suh, et al.

    Objective: Long‐term multidimensional evaluations of pediatric lung transplantation are limited. This study assessed the functional recovery, volumetric adaptation, and growth in pediatric recipients by comparing age and graft type. Methods: This single‐center, retrospective, descriptive study longitudinally reviewed 16 children (age < 18 years) who underwent bilateral deceased‐donor lung transplantation. Perioperative characteristics, pulmonary function, computed tomography (CT)–derived lung volume, somatic growth, and survival were analyzed. Overall survival (OS) and chronic lung allograft dysfunction (CLAD)–free survival were estimated using the Kaplan–Meier method, and longitudinal physiological and developmental patterns were assessed descriptively. Results: In the younger group (≤ 10 years, n = 7) and the older group (> 10 years, n = 9), lobar transplantation was performed in 5 (71.4%) and 3 (33.3%) patients, respectively. CLAD was diagnosed in 1 younger recipient (14.3%) and 2 older recipients (22.2%). OS did not differ significantly between age groups (log‐rank p = 0.96), and CLAD‐free survival was comparable (log‐rank p = 0.73). CT volumetry demonstrated progressive postoperative lung expansion with similar temporal trajectories across age groups and between lobar and whole‐lung grafts. Growth patterns demonstrated meaningful postoperative improvement, with many children who exhibited faltering pretransplant growth demonstrating catch‐up toward individualized percentile curves. Conclusions: Pediatric lung transplantation results in favorable long‐term recovery, including functional improvement, durable volumetric adaptation, and partial restoration of growth dynamics. Comparable outcomes between lobar and whole‐lung grafts support the use of size‐reduced grafts in cases of donor–recipient mismatch.

  • Open Access

    Long-Term Outcomes of Indocyanine Green Versus Inflation-Deflation for Intersegmental Plane Identification in Segmentectomy for Early-Stage Lung Cancer

    by Seon Yong Bae, Dae Hyeon Kim, Taeyoung Yun, Ji Hyeon Park, Bubse Na, Kwon Joong Na, Samina Park, Hyun Joo Lee, In Kyu Park, Chang Hyun Kang, et al.

    Objectives: This study aimed to evaluate whether the method of intersegmental plane (ISP) identification—indocyanine green (ICG) fluorescence vs the conventional inflation-deflation (ID) technique—affects resection margin adequacy, oncologic outcomes, or postoperative pulmonary function after anatomical segmentectomy for early-stage non–small-cell lung cancer (NSCLC). Methods: We retrospectively analysed 410 patients who underwent segmentectomy for clinical N0M0 NSCLC between January 2018 and December 2023. The ISP was identified using the ID and ICG methods in 286 and 124 patients, respectively. Perioperative, pathologic, and survival outcomes were compared before and after inverse probability of treatment weighting (IPTW). Results: Operative time and hospital stay were slightly shorter in the ICG than in the ID group (108.0 vs 115.0 min, P = .031; 4.0 vs 5.0 days, P = .003), whereas postoperative complication rates and pulmonary function changes were comparable. Central resection margins were longer in the ID group (2.5 vs 2.0 cm, P = .014), whereas lateral margin distances did not differ significantly. Recurrence-free and overall survival were similar between the 2 groups (log-rank P = .97 and P = .18). In IPTW-adjusted multivariable Cox analysis, the ISP identification method was not associated with recurrence or survival. Conclusions: The ISP identification method was not associated with differences in functional or oncologic outcomes after anatomical segmentectomy. These findings suggest that the choice of technique may be guided by surgeon preference and technical considerations.

  • Open Access

    Spatial Transcriptomics Reveals a Conserved Border Niche and Etiology-Associated Immune Rewiring in Hepatocellular Carcinoma

    by Sungwoo Bae, Hongyoon Choi, Su Young Hong, YoungRok Choi, Kwang-Woong Lee, Kwon Joong Na, Suk Kyun Hong

    Background and Aims: The tumor-stroma interface in hepatocellular carcinoma (HCC) harbors critical intercellular interactions that shape immune evasion and treatment response, yet its spatial architecture remains poorly characterized across etiologies. Whether hepatitis B virus (HBV)-related and non-B non-C (NBNC) HCC share conserved border niche features or exhibit etiology-specific microenvironment programs is unknown. We aimed to spatially resolve the tumor boundary ecosystem and identify etiology-associated signaling networks with translational relevance. Approach and Results: We performed 10x Visium spatial transcriptomics on 11 HCC specimens (7 HBV, 4 NBNC) and applied a machine-learning pipeline integrating CancerFinder and SpaceFlow to define tumor, boundary, and stromal domains. Across etiologies, the boundary zone showed a recurrent desmoplastic niche characterized by cancer-associated fibroblast, tumor-associated macrophage, and tumor endothelial cell accumulation with collagen-integrin extracellular matrix remodeling, including COL1A1-ITGA11 and COL4A1-ITGAV. Etiology-associated differences were observed in the organization of border-zone signaling programs. In representative HBV-related sections, CCL19-CCR7 signaling showed a comparatively restricted, endothelial-skewed topology, whereas representative NBNC sections showed broader inflammatory ligand-receptor networks with elevated NF-kB-associated pathway activity. Conclusions: The HCC tumor-stroma border harbors a recurrent desmoplastic niche upon which etiology-associated immune regulatory programs may be superimposed. These findings generate spatial hypotheses relevant to etiology-informed biomarker development and future therapeutic stratification.

  • Open Access

    Spatial tumor microenvironmental architecture of chemoradiotherapy-resistant residual esophageal squamous cell carcinoma

    by Sungwoo Bae, Jungyoon Ohn, Hongyoon Choi, Hye Seung Lee, Bhumsuk Kim, Chang Hyun Kang, Hak Jae Kim, Kwon Joong Na, Byoung Hyuck Kim

    Purpose: Residual ESCC after neoadjuvant CCRT reflects incomplete treatment response and carries a high risk of recurrence. We sought to define the spatial tumor microenvironmental features of CCRT-resistant residual ESCC (using tumor regression grade (TRG) 2 or 3 tumors as a model of poor pathologic response) with mechanistic refinement at single-cell resolution and outcome assessment in internal and external cohorts. Experimental Design: We profiled post CCRT ESCC tissue microarray (TMA) cores by Visium FFPE whole-transcriptome spatial transcriptomics and orthogonal Xenium single-cell-resolution in situ profiling on serial sections from the same TMA blocks. Spot-level cell-type composition was inferred by CellDART deconvolution against a published ESCC single-cell RNA sequencing (scRNAseq). Local malignant-cell-enriched regions were defined by CancerFinder. We additionally re-analyzed the scRNAseq dataset to characterize SPP1+ and CXCL5+ macrophage states and their ligand-receptor signaling using CellChat. Outcome associations were evaluated in the SNUH cohort and externally tested in the TCGA ESCC cohort. Results: TRG 2-3 residual tumors exhibited effector immune-cell exclusion from malignant-cell-enriched regions, SPP1+/CXCL5+ macrophage accumulation, microvascular rarefaction, and proliferative-metabolic reprogramming. Single-cell re-analysis confirmed that CXCL5+ macrophages constitute a transcriptional subset of the broader SPP1+ macrophage population. CellChat showed that SPP1+ macrophages dominantly signal through SPP1-CD44 and SPP1-integrin axes to stromal and epithelial targets, and additionally engage immunosuppressive NECTIN2-TIGIT, CD86-CTLA4, and LGALS9-HAVCR2 programs with CD8 T cells, providing a mechanistic context for local immune exclusion. Visium LIANA and Xenium distance-gradient profiling localized SPP1-associated signaling preferentially to tumor cells and CAFs. Higher SPP1 expression and lower endothelial abundance were associated with shorter disease-free survival in the SNUH cohort. Higher SPP1 expression was also associated with shorter disease-free survival in the independent TCGA ESCC cohort. Conclusions: CCRT-resistant residual ESCC is characterized by a spatially organized tumor microenvironmental niche centered on SPP1-associated macrophage programs and microvascular rarefaction. These spatially resolved findings identify candidate macrophage- and vasculature-targeted axes for overcoming treatment resistance.

  • Open Access

    Analysis of unmapped RNA-seq data from cancer spatial transcriptome toward characterizing cancer microbiome

    by Seo Hye Park, Jeongbin Park, Jiwon Kim, Hongyoon Choi, In Gul Kim, Eun Jae Chung, Kwon Joong Na

    Spatial characterization of microbial-like signals in tumor tissues remains challenging, particularly in direct Visium data, where microbial reads are sparse and may not be fully retained in standard count matrices. Here, we present an extended unmapped-read analysis as a proof-of-concept workflow for summarizing microbial-like 16S rRNA signals in four direct Visium specimens from colorectal cancer (CRC), oral squamous cell carcinoma (OSCC), and head and neck squamous cell carcinoma (HNSC). The workflow uses a custom reference containing four selected 16S rRNA sequences and computes a per-spot mismatch ratio to quantify sequence-level dissimilarity relative to each reference. Compared with PathSeq, the workflow yielded different spatial signal patterns and mismatch summaries across the analyzed specimens. Among the four tested references, the CRC specimen showed lower mismatch ratios relative to the E. coli reference than the other analyzed specimens, an observation compatible with the intestinal context but not definitive evidence of species-level presence or evolutionary proximity. Given the small sample set, restricted reference panel, and lack of dedicated negative controls, these findings should be interpreted as hypothesis-generating. This study provides a complementary proof-of-concept framework for exploring microbial-like signals in direct Visium data.

  • Open Access

    Response to “Unequal Local Anesthetic Dosing and Surgical Heterogeneity: Considerations for Interpreting the ESPB–TEA Non-Inferiority Trial” [Response to Letter]

    by Sooah Cho, Ho-Jin Lee, Soo-Hyuk Yoon, Sang-Youn Park, Samina Park, Hyun Joo Lee, In Kyu Park, Chang Hyun Kang, Kwon Joong Na, Susie Yoon, et al.

    Response to Letter in regards to Unequal Local Anesthetic Dosing and Surgical Heterogeneity: Considerations for Interpreting the ESPB–TEA Non-Inferiority Trial [Letter]

  • Open Access

    Distinct Spatial Programs of Response versus Resistance in Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy

    by Seo Hye Park, Jaemoon Koh, Sungwoo Bae, Hongyoon Choi, Taeyoung Yun, Ji Hyeon Park, Bubse Na, Samina Park, Hyun Joo Lee, In Kyu Park, et al.

    Background: Neoadjuvant chemoimmunotherapy (nCIT) has become a standard treatment for locally advanced resectable non-small cell lung cancer (NSCLC), yet the spatial biology underlying treatment resistance remains poorly understood. We used spatial transcriptomics to define the microenvironmental architecture of residual cancers in patients who did not achieve major pathologic response (non-MPR) compared with those who did (MPR). Methods: Spatial transcriptomics was performed on 10 formalin-fixed paraffin-embedded tumor blocks (5 MPR, 5 non-MPR) obtained from 8 patients treated with nCIT. A deep learning algorithm was applied to detect viable residual cancer spots from treatment-induced fibrosis and necrosis. Spatial deconvolution, distance modeling, ligand-receptor analysis, and functional pathway scoring were integrated to characterize niche-specific programs. Results: MPR cancer core displayed an immune-permissive remodeling environment with deep infiltration of cytotoxic CD8+ T cells, mature dendritic cells (LAMP3+, CCR7+), and active efferocytosis signaling (APOE-TREM2), alongside robust MHC class II expression. Non-MPR cancer core, by contrast, exhibited spatial immune exclusion: a dense fibroblast barrier reinforced by TIMP1-CD63 signaling and Treg-enriched boundaries physically restricted effector T cell access to the cancer core. Residual cancer cells in non-MPR samples maintained active cell cycling and independently upregulated cytochrome P450-mediated drug detoxification and DNA damage response pathways without inducing MHC class II expression - effectively decoupling intrinsic survival from immune recognition. The non-MPR core also showed a hyper-metabolic profile, including elevated glutathione metabolism consistent with antioxidant buffering against chemotherapy-induced oxidative stress. TROP2 was broadly expressed across the non-MPR cancer core and colocalized with DNA damage response and nuclear factor erythroid 2-related factor 2 resistance signatures. Conclusions: Residual cancer cores in non-MPR tumors appear to represent evolved resistant niches sustained by structural immune exclusion, metabolic rewiring, and DNA repair proficiency. These findings highlight the spatial co-localization of epithelial anchors, such as TROP2, with intrinsic resistance pathways, providing a structural rationale for developing novel precision therapeutic strategies to bypass stromal barriers and overcome the cancer core's intrinsic repair capacity.

  • Robot-Assisted Versus Video-Assisted Thymectomy: A Narrative Review of Current Evidence

    by Seon Yong Bae, Kwon Joong Na

    Objectives: Minimally invasive thymectomy has transformed the surgical management of thymic epithelial tumours and myasthenia gravis (MG). Video-assisted thoracoscopic surgery (VATS) is well established, whereas robot-assisted thoracoscopic surgery (RATS) provides technical and ergonomic advantages but at a higher cost. We reviewed current evidence to clarify the indications, oncological validity, perioperative performance, and economic implications of RATS compared with VATS and open thymectomy. Methods: A structured narrative review was conducted, drawing on multi-institutional cohorts, registry-based propensity-matched studies, and systematic reviews. Evidence was organized by tumour characteristics, special populations (MG, obesity, recurrent thymoma), perioperative and long-term outcomes, surgeon-centred considerations, and cost-effectiveness. Results: In early-stage thymoma and MG, both VATS and RATS achieve R0 resection rates ≥95% and recurrence outcomes comparable with sternotomy. Robot-assisted thoracoscopic surgery is associated with lower blood loss, fewer conversions, and signals of faster recovery, with particular advantages in obese or redo cases. Long-term survival appears equivalent across minimally invasive approaches, without evidence of oncological superiority. However, RATS incurs higher per-case costs, primarily from instrumentation and platform expenses. Conclusions: VATS remains efficient for straightforward cases, whereas RATS may safely extend minimally invasive eligibility to anatomically complex scenarios while maintaining oncological integrity. Adoption should be indication-driven and resource-conscious. Further multicentre studies with long-term follow-up, patient-reported outcomes, and cost-effectiveness analyses are needed to define the sustainable role of RATS in thymectomy. Clinical registration number: Not applicable.

  • Open Access

    Continuous Erector Spinae Plane Block versus Thoracic Epidural Analgesia After Thoracotomy: A Randomized Controlled Assessor-Blinded Non-Inferiority Trial

    by Sooah Cho, Ho-Jin Lee, Soo-Hyuk Yoon, Sang-Youn Park, Samina Park, Hyun Joo Lee, In Kyu Park, Chang Hyun Kang, Kwon Joong Na, Susie Yoon, et al.

    Purpose: Thoracic epidural analgesia (TEA) remains the current gold standard for postoperative pain control after thoracotomy, but is associated with significant complications and contraindications. This study evaluated whether continuous erector spinae plane block (ESPB) provides non-inferior analgesia to TEA. Patients and Methods: Adult patients scheduled for elective thoracotomy were randomized 1:1 to receive continuous TEA or ESPB. Outcome assessors were blinded to group allocation. In the TEA group, an epidural catheter was inserted at T6– 7 under fluoroscopic guidance with tip confirmation at T5. In the ESPB group, a catheter was placed under ultrasound guidance at the T5 transverse process. Both groups received 0.2% ropivacaine boluses before incision, followed by patient-controlled analgesia for three days. The primary endpoint was resting numeric rating scale pain score on postoperative day 1 with a 2-point non-inferiority margin. Secondary endpoints included pain scores on days 2– 3, opioid consumption, QoR-15K scores, and chronic pain assessments at 3 and 6 months. Results: Fifty-three patients were enrolled; 44 were included in the modified intention-to-treat analysis (ESPB n=23; TEA n=21). Mean resting NRS scores on postoperative day 1 were 4.22± 1.93 (ESPB) versus 4.81± 1.78 (TEA). The between-group difference was − 0.59 (95% CI, − 1.72– 0.54; P=0.296), meeting the predefined non-inferiority margin. Secondary outcomes, including pain scores, opioid consumption, Quality of Recovery-15 scores, and chronic pain assessments at 3 and 6 months, were comparable between groups. No major complications occurred. Conclusion: Continuous ESPB demonstrated analgesic efficacy comparable to TEA for postoperative pain control after thoracotomy. Combined with its superior safety profile and technical simplicity, ESPB may serve as an effective alternative to TEA in thoracic surgery.